Sort   by:  
 Page size 
UnknownSustained remissions in CLL after frontline FCR treatment with very-long-term follow-up.
Not available
S-EPMC11383921 | biostudies-literature
UnknownAxicabtagene ciloleucel as first-line therapy in high-risk large B-cell lymphoma: the phase 2 ZUMA-12 trial.
Not available
S-EPMC9018426 | biostudies-literature
UnknownPhase II study of the MEK1/MEK2 inhibitor Trametinib in patients with metastatic BRAF-mutant cutaneous melanoma previously treated with or without a BRAF inhibitor.
Not available
S-EPMC4878037 | biostudies-literature
UnknownPhase I/II study of the antibody-drug conjugate glembatumumab vedotin in patients with advanced melanoma.
Not available
S-EPMC4879709 | biostudies-literature
UnknownOutcome and Prognostic Factors in Stage III Favorable-Histology Wilms Tumor: A Report From the Children's Oncology Group Study AREN0532.
Not available
S-EPMC5773840 | biostudies-literature
UnknownNetie: inferring the evolution of neoantigen-T cell interactions in tumors.
Not available
S-EPMC10083098 | biostudies-literature
UnknownAssessment of Ovarian Function in Phase III (Neo)Adjuvant Breast Cancer Clinical Trials: A Systematic Evaluation.
Not available
S-EPMC8634391 | biostudies-literature
UnknownStereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus.
Not available
S-EPMC9843697 | biostudies-literature
UnknownTreatment of Stage IV Favorable Histology Wilms Tumor With Lung Metastases: A Report From the Children's Oncology Group AREN0533 Study.
Not available
S-EPMC6075846 | biostudies-literature
UnknownDose-intensive response-based chemotherapy and radiation therapy for children and adolescents with newly diagnosed intermediate-risk hodgkin lymphoma: a report from the Children's Oncology Group Study AHOD0031.
Not available
S-EPMC4220044 | biostudies-literature
Sort   by:  
 Page size